Skip to main content
Clinical Trials/CTRI/2023/07/055420
CTRI/2023/07/055420Not yet recruitingPhase 3

Clinical evaluation of herbal formulation in Mild to Moderate Contact Dermatitis - NI

Plant Ayu Life Sciences LLP Pune0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1.Age from 18 - 60 yrs
  • 2.Mild to moderate SCORing Atopic Dermatitis (SCORAD) > 5 % for > 1 months
  • 3.Body surface involvement (BSI) of > 5%
  • 4.Male or female
  • 5.Willing to provide voluntary written informed consent.

Exclusion Criteria

  • 1)Pregnant women and lactating mothers.
  • 2)Patients suffering from systemic disorders as Cardiac, renal and hepatic diseases, Uncontrolled Diabetes mellitus, Uncontrolled Hypertension, Paralysis, Malignancy, Human immune deficiency virus infection, HBsAg, Leprosy.
  • 3)Patients suffering from Psoriatic arthritis.
  • 4)Patients who have received systemic therapy for psoriasis or those who have been treated with immunosuppressive immune - modulating treatment in previous 8 weeks.
  • 5)Patient with personal or family history of malignant or premalignant skin tumours.
  • 6)Subject with active infection either acute or chronic by fungi, viruses bacteria and parasites

Investigators

Sponsor
Plant Ayu Life Sciences LLP Pune

Similar Trials